カテゴリー： Market Monitor Global, 世界, 医療/バイオ

胃酸分泌抑薬の世界市場見通し2023年-2029年

◆英語タイトル：Gastric Antisecretory Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5577）

◆商品コード：MMG23JU5577
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：74
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Gastric Antisecretory Drug Market 調査レポートは次の情報を含め、グローバルにおけるの胃酸分泌抑薬市場規模と予測を収録しています。・世界の胃酸分泌抑薬市場：売上、2018年-2023年、2024年-2029年
・世界の胃酸分泌抑薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の胃酸分泌抑薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「H2受容体拮抗薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

胃酸分泌抑薬のグローバル主要企業は、Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxinなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、胃酸分泌抑薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の胃酸分泌抑薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の胃酸分泌抑薬市場：タイプ別市場シェア、2022年
・H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他

世界の胃酸分泌抑薬市場：用途別、2018年-2023年、2024年-2029年
世界の胃酸分泌抑薬市場：用途別市場シェア、2022年
・消化不良、消化性潰瘍、胃食道逆流症、その他

世界の胃酸分泌抑薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の胃酸分泌抑薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における胃酸分泌抑薬のグローバル売上、2018年-2023年
・主要企業における胃酸分泌抑薬のグローバル売上シェア、2022年
・主要企業における胃酸分泌抑薬のグローバル販売量、2018年-2023年
・主要企業における胃酸分泌抑薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxin

*************************************************************

・調査・分析レポートの概要
胃酸分泌抑薬市場の定義
市場セグメント
世界の胃酸分泌抑薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の胃酸分泌抑薬市場規模
世界の胃酸分泌抑薬市場規模：2022年 VS 2029年
世界の胃酸分泌抑薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの胃酸分泌抑薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の胃酸分泌抑薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他
胃酸分泌抑薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：消化不良、消化性潰瘍、胃食道逆流症、その他
胃酸分泌抑薬の用途別グローバル売上・予測

・地域別市場分析
地域別胃酸分泌抑薬市場規模 2022年と2029年
地域別胃酸分泌抑薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Cadila Pharmaceuticals、 AstraZeneca、 Jiangsu Aosaikang、 Eisai、 Pfizer、 Altana Pharma、 Takeda、 NCPC、 Luoxin
...

Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.
This report aims to provide a comprehensive presentation of the global market for Gastric Antisecretory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Antisecretory Drug. This report contains market size and forecasts of Gastric Antisecretory Drug in global, including the following market information:
Global Gastric Antisecretory Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastric Antisecretory Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gastric Antisecretory Drug companies in 2022 (%)
The global Gastric Antisecretory Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
H2-receptor Antagonists Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastric Antisecretory Drug include Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda and NCPC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastric Antisecretory Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Antisecretory Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Type, 2022 (%)
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others
Global Gastric Antisecretory Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Application, 2022 (%)
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others
Global Gastric Antisecretory Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Antisecretory Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastric Antisecretory Drug revenues share in global market, 2022 (%)
Key companies Gastric Antisecretory Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastric Antisecretory Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastric Antisecretory Drug, market overview.
Chapter 2: Global Gastric Antisecretory Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Gastric Antisecretory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastric Antisecretory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastric Antisecretory Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Gastric Antisecretory Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Antisecretory Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Antisecretory Drug Overall Market Size
2.1 Global Gastric Antisecretory Drug Market Size: 2022 VS 2029
2.2 Global Gastric Antisecretory Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastric Antisecretory Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Gastric Antisecretory Drug Players in Global Market
3.2 Top Global Gastric Antisecretory Drug Companies Ranked by Revenue
3.3 Global Gastric Antisecretory Drug Revenue by Companies
3.4 Global Gastric Antisecretory Drug Sales by Companies
3.5 Global Gastric Antisecretory Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastric Antisecretory Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastric Antisecretory Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Antisecretory Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastric Antisecretory Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Antisecretory Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gastric Antisecretory Drug Market Size Markets, 2022 & 2029
4.1.2 H2-receptor Antagonists
4.1.3 Gastric Proton Pump Inhibitors
4.1.4 Others
4.2 By Type – Global Gastric Antisecretory Drug Revenue & Forecasts
4.2.1 By Type – Global Gastric Antisecretory Drug Revenue, 2018-2023
4.2.2 By Type – Global Gastric Antisecretory Drug Revenue, 2024-2029
4.2.3 By Type – Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Gastric Antisecretory Drug Sales & Forecasts
4.3.1 By Type – Global Gastric Antisecretory Drug Sales, 2018-2023
4.3.2 By Type – Global Gastric Antisecretory Drug Sales, 2024-2029
4.3.3 By Type – Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
4.4 By Type – Global Gastric Antisecretory Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gastric Antisecretory Drug Market Size, 2022 & 2029
5.1.2 Dyspepsia
5.1.3 Peptic Ulcer
5.1.4 Gastroesophageal Reflux
5.1.5 Others
5.2 By Application – Global Gastric Antisecretory Drug Revenue & Forecasts
5.2.1 By Application – Global Gastric Antisecretory Drug Revenue, 2018-2023
5.2.2 By Application – Global Gastric Antisecretory Drug Revenue, 2024-2029
5.2.3 By Application – Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Gastric Antisecretory Drug Sales & Forecasts
5.3.1 By Application – Global Gastric Antisecretory Drug Sales, 2018-2023
5.3.2 By Application – Global Gastric Antisecretory Drug Sales, 2024-2029
5.3.3 By Application – Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
5.4 By Application – Global Gastric Antisecretory Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gastric Antisecretory Drug Market Size, 2022 & 2029
6.2 By Region – Global Gastric Antisecretory Drug Revenue & Forecasts
6.2.1 By Region – Global Gastric Antisecretory Drug Revenue, 2018-2023
6.2.2 By Region – Global Gastric Antisecretory Drug Revenue, 2024-2029
6.2.3 By Region – Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Gastric Antisecretory Drug Sales & Forecasts
6.3.1 By Region – Global Gastric Antisecretory Drug Sales, 2018-2023
6.3.2 By Region – Global Gastric Antisecretory Drug Sales, 2024-2029
6.3.3 By Region – Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gastric Antisecretory Drug Revenue, 2018-2029
6.4.2 By Country – North America Gastric Antisecretory Drug Sales, 2018-2029
6.4.3 US Gastric Antisecretory Drug Market Size, 2018-2029
6.4.4 Canada Gastric Antisecretory Drug Market Size, 2018-2029
6.4.5 Mexico Gastric Antisecretory Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gastric Antisecretory Drug Revenue, 2018-2029
6.5.2 By Country – Europe Gastric Antisecretory Drug Sales, 2018-2029
6.5.3 Germany Gastric Antisecretory Drug Market Size, 2018-2029
6.5.4 France Gastric Antisecretory Drug Market Size, 2018-2029
6.5.5 U.K. Gastric Antisecretory Drug Market Size, 2018-2029
6.5.6 Italy Gastric Antisecretory Drug Market Size, 2018-2029
6.5.7 Russia Gastric Antisecretory Drug Market Size, 2018-2029
6.5.8 Nordic Countries Gastric Antisecretory Drug Market Size, 2018-2029
6.5.9 Benelux Gastric Antisecretory Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gastric Antisecretory Drug Revenue, 2018-2029
6.6.2 By Region – Asia Gastric Antisecretory Drug Sales, 2018-2029
6.6.3 China Gastric Antisecretory Drug Market Size, 2018-2029
6.6.4 Japan Gastric Antisecretory Drug Market Size, 2018-2029
6.6.5 South Korea Gastric Antisecretory Drug Market Size, 2018-2029
6.6.6 Southeast Asia Gastric Antisecretory Drug Market Size, 2018-2029
6.6.7 India Gastric Antisecretory Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gastric Antisecretory Drug Revenue, 2018-2029
6.7.2 By Country – South America Gastric Antisecretory Drug Sales, 2018-2029
6.7.3 Brazil Gastric Antisecretory Drug Market Size, 2018-2029
6.7.4 Argentina Gastric Antisecretory Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gastric Antisecretory Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gastric Antisecretory Drug Sales, 2018-2029
6.8.3 Turkey Gastric Antisecretory Drug Market Size, 2018-2029
6.8.4 Israel Gastric Antisecretory Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Gastric Antisecretory Drug Market Size, 2018-2029
6.8.6 UAE Gastric Antisecretory Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Gastric Antisecretory Drug Major Product Offerings
7.1.4 Bayer Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Company Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Major Product Offerings
7.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.2.5 Cadila Pharmaceuticals Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Gastric Antisecretory Drug Major Product Offerings
7.3.4 AstraZeneca Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Jiangsu Aosaikang
7.4.1 Jiangsu Aosaikang Company Summary
7.4.2 Jiangsu Aosaikang Business Overview
7.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Major Product Offerings
7.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.4.5 Jiangsu Aosaikang Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Gastric Antisecretory Drug Major Product Offerings
7.5.4 Eisai Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastric Antisecretory Drug Major Product Offerings
7.6.4 Pfizer Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Altana Pharma
7.7.1 Altana Pharma Company Summary
7.7.2 Altana Pharma Business Overview
7.7.3 Altana Pharma Gastric Antisecretory Drug Major Product Offerings
7.7.4 Altana Pharma Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.7.5 Altana Pharma Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Gastric Antisecretory Drug Major Product Offerings
7.8.4 Takeda Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 NCPC
7.9.1 NCPC Company Summary
7.9.2 NCPC Business Overview
7.9.3 NCPC Gastric Antisecretory Drug Major Product Offerings
7.9.4 NCPC Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.9.5 NCPC Key News & Latest Developments
7.10 Luoxin
7.10.1 Luoxin Company Summary
7.10.2 Luoxin Business Overview
7.10.3 Luoxin Gastric Antisecretory Drug Major Product Offerings
7.10.4 Luoxin Gastric Antisecretory Drug Sales and Revenue in Global (2018-2023)
7.10.5 Luoxin Key News & Latest Developments
8 Global Gastric Antisecretory Drug Production Capacity, Analysis
8.1 Global Gastric Antisecretory Drug Production Capacity, 2018-2029
8.2 Gastric Antisecretory Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Antisecretory Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Antisecretory Drug Supply Chain Analysis
10.1 Gastric Antisecretory Drug Industry Value Chain
10.2 Gastric Antisecretory Drug Upstream Market
10.3 Gastric Antisecretory Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Antisecretory Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Gastric Antisecretory Drug in Global Market
Table 2. Top Gastric Antisecretory Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastric Antisecretory Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastric Antisecretory Drug Revenue Share by Companies, 2018-2023
Table 5. Global Gastric Antisecretory Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Gastric Antisecretory Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastric Antisecretory Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gastric Antisecretory Drug Product Type
Table 9. List of Global Tier 1 Gastric Antisecretory Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastric Antisecretory Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gastric Antisecretory Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gastric Antisecretory Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastric Antisecretory Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gastric Antisecretory Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Gastric Antisecretory Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Gastric Antisecretory Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gastric Antisecretory Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastric Antisecretory Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gastric Antisecretory Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Gastric Antisecretory Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Gastric Antisecretory Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gastric Antisecretory Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastric Antisecretory Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gastric Antisecretory Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Gastric Antisecretory Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastric Antisecretory Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gastric Antisecretory Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Gastric Antisecretory Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastric Antisecretory Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gastric Antisecretory Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gastric Antisecretory Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastric Antisecretory Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gastric Antisecretory Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gastric Antisecretory Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastric Antisecretory Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gastric Antisecretory Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Gastric Antisecretory Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastric Antisecretory Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gastric Antisecretory Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gastric Antisecretory Drug Sales, (K Units), 2024-2029
Table 46. Bayer Company Summary
Table 47. Bayer Gastric Antisecretory Drug Product Offerings
Table 48. Bayer Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Cadila Pharmaceuticals Company Summary
Table 51. Cadila Pharmaceuticals Gastric Antisecretory Drug Product Offerings
Table 52. Cadila Pharmaceuticals Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Cadila Pharmaceuticals Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Gastric Antisecretory Drug Product Offerings
Table 56. AstraZeneca Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Jiangsu Aosaikang Company Summary
Table 59. Jiangsu Aosaikang Gastric Antisecretory Drug Product Offerings
Table 60. Jiangsu Aosaikang Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Jiangsu Aosaikang Key News & Latest Developments
Table 62. Eisai Company Summary
Table 63. Eisai Gastric Antisecretory Drug Product Offerings
Table 64. Eisai Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Eisai Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Gastric Antisecretory Drug Product Offerings
Table 68. Pfizer Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Altana Pharma Company Summary
Table 71. Altana Pharma Gastric Antisecretory Drug Product Offerings
Table 72. Altana Pharma Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Altana Pharma Key News & Latest Developments
Table 74. Takeda Company Summary
Table 75. Takeda Gastric Antisecretory Drug Product Offerings
Table 76. Takeda Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Takeda Key News & Latest Developments
Table 78. NCPC Company Summary
Table 79. NCPC Gastric Antisecretory Drug Product Offerings
Table 80. NCPC Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. NCPC Key News & Latest Developments
Table 82. Luoxin Company Summary
Table 83. Luoxin Gastric Antisecretory Drug Product Offerings
Table 84. Luoxin Gastric Antisecretory Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Luoxin Key News & Latest Developments
Table 86. Gastric Antisecretory Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Gastric Antisecretory Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Gastric Antisecretory Drug Production by Region, 2018-2023 (K Units)
Table 89. Global Gastric Antisecretory Drug Production by Region, 2024-2029 (K Units)
Table 90. Gastric Antisecretory Drug Market Opportunities & Trends in Global Market
Table 91. Gastric Antisecretory Drug Market Drivers in Global Market
Table 92. Gastric Antisecretory Drug Market Restraints in Global Market
Table 93. Gastric Antisecretory Drug Raw Materials
Table 94. Gastric Antisecretory Drug Raw Materials Suppliers in Global Market
Table 95. Typical Gastric Antisecretory Drug Downstream
Table 96. Gastric Antisecretory Drug Downstream Clients in Global Market
Table 97. Gastric Antisecretory Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastric Antisecretory Drug Segment by Type in 2022
Figure 2. Gastric Antisecretory Drug Segment by Application in 2022
Figure 3. Global Gastric Antisecretory Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastric Antisecretory Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastric Antisecretory Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Gastric Antisecretory Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastric Antisecretory Drug Revenue in 2022
Figure 9. By Type - Global Gastric Antisecretory Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Gastric Antisecretory Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Gastric Antisecretory Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Gastric Antisecretory Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Gastric Antisecretory Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gastric Antisecretory Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 23. US Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 28. Germany Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 37. China Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 44. Brazil Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gastric Antisecretory Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gastric Antisecretory Drug Sales Market Share, 2018-2029
Figure 48. Turkey Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gastric Antisecretory Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gastric Antisecretory Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gastric Antisecretory Drug by Region, 2022 VS 2029
Figure 54. Gastric Antisecretory Drug Industry Value Chain
Figure 55. Marketing Channels

※参考情報

胃酸分泌抑薬は、胃の中で分泌される酸を抑制するために使用される薬剤の総称であり、主に消化器系の治療において重要な役割を果たします。これらの薬剤は、胃酸過多による症状や病気を改善するために用いられ、さまざまなメカニズムを持っています。ここでは、胃酸分泌抑薬の定義、特徴、種類、用途、関連技術などについて詳しく説明いたします。

胃酸分泌抑薬の定義は、胃の粘膜やその他の消化器系の病状に影響を与える酸性分泌を抑える薬剤であり、通常、逆流性食道炎や胃潰瘍、十二指腸潰瘍などの治療に用いられます。胃酸は主に胃の壁細胞から分泌され、消化の過程で重要な役割を果たしますが、過剰な分泌はさまざまな消化器系の問題を引き起こす可能性があります。そのため、胃酸分泌抑薬は、胃酸の分泌量を調整することで、病状の改善を図ります。

特徴としては、胃酸分泌抑薬は主に以下のような特性を持っています。まず第一に、薬効が数時間から数日の間持続することが多い点です。これにより、患者が日常生活を送る上での負担を軽減させることができます。また、副作用が比較的少ないことも特徴として挙げられます。しかし、長期間の使用により、低カルシウム血症やビタミンB12欠乏症などの問題が生じることがあるため、注意が必要です。

種類としては、大きく分けて2つのカテゴリーに分類することができます。一つは、プロトンポンプ阻害薬（PPIs）であり、もう一つはヒスタミンH2受容体拮抗薬です。プロトンポンプ阻害薬は、胃の壁細胞に存在するプロトンポンプを直接阻害することで、胃酸の分泌を抑えるメカニズムを持っています。一般的な薬剤には、オメプラゾールやエソメプラゾールなどがあります。これらの薬剤は、強力かつ持続的に酸分泌を抑制するため、特に重症の胃潰瘍や逆流性食道炎の治療に頻繁に使用されます。

一方、ヒスタミンH2受容体拮抗薬は、胃の酸分泌を刺激するヒスタミンに対する受容体をブロックすることで、その分泌を抑える薬剤です。代表的なものに、ラニチジンやファモチジンがあります。これらの薬剤は、プロトンポンプ阻害薬に比べて効果がやや劣りますが、短期的な治療や軽症の症状に対しては有効です。

用途に関しては、胃酸分泌抑薬は主に消化性潰瘍の治療に用いられます。特に、胃潰瘍や十二指腸潰瘍の治療においては、粘膜の保護促進や潰瘍の治癒を目的として使用されます。逆流性食道炎の場合、食道への胃酸の逆流を防ぐために、これらの薬剤は重要な役割を果たします。また、消化器系の手術において術後の胃酸過多を防止するための予防的な目的でも使用されることがあります。

さらに、胃酸分泌抑薬は、ストレスや不規則な生活習慣によって引き起こされる一過性の胃酸過多に対する治療としても利用されます。これにより、患者が感じる不快な症状を軽減することができます。

関連技術に関しては、近年では新しい薬剤の開発が進められており、より効果的で副作用の少ない薬剤が期待されています。例えば、プロトンポンプ阻害薬の持続的な開発に加え、ターゲット治療としての可能性を探る研究も行われています。また、遺伝子解析技術の進展により、個々の患者に最適な治療法の選択が可能になるかもしれません。

総じて、胃酸分泌抑薬は消化器系の疾患において非常に重要な位置を占めており、様々な病状に応じた治療法としての役割が期待されています。医療現場においては、その使用に際して注意が必要であり、適切な診断と治療方針に基づいて処方されることが重要です。したがって、患者自身も自分の症状を正確に理解し、医師と協力して治療に臨むことが求められます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 胃酸分泌抑薬の世界市場見通し2023年-2029年(Gastric Antisecretory Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

胃酸分泌抑薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp